Woods GL - Search Results

1

In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics.

Friedland I, Mixson LA, Majumdar A, Motyl M, Woods GL. Friedland I, et al. Among authors: woods gl. J Chemother. 2002 Oct;14(5):483-91. doi: 10.1179/joc.2002.14.5.483. J Chemother. 2002. PMID: 12462428

2

Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections.

Pelak BA, Woods GL, Teppler H, Friedland I, Bartizal K, Motyl M. Pelak BA, et al. Among authors: woods gl. J Chemother. 2002 Jun;14(3):227-33. doi: 10.1179/joc.2002.14.3.227. J Chemother. 2002. PMID: 12120874

3

Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections.

Hicks PS, Pelak B, Woods GL, Bartizal KF, Motyl M. Hicks PS, et al. Among authors: woods gl. Clin Microbiol Infect. 2002 Nov;8(11):753-7. doi: 10.1046/j.1469-0691.2002.00461.x. Clin Microbiol Infect. 2002. PMID: 12445016 Free article.

4

Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States.

Friedland I, Gallagher G, King T, Woods GL. Friedland I, et al. Among authors: woods gl. J Chemother. 2004 Oct;16(5):437-41. doi: 10.1179/joc.2004.16.5.437. J Chemother. 2004. PMID: 15565908

5

Use of surrogate antimicrobial agents to predict susceptibility to ertapenem.

Friedland IR, Isaacs R, Mixson LA, Motyl M, Woods GL. Friedland IR, et al. Among authors: woods gl. Diagn Microbiol Infect Dis. 2002 May;43(1):61-4. doi: 10.1016/s0732-8893(02)00380-2. Diagn Microbiol Infect Dis. 2002. PMID: 12052630

6

Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.

Pelak BA, Bartizal K, Woods GL, Gesser RM, Motyl M. Pelak BA, et al. Among authors: woods gl. Diagn Microbiol Infect Dis. 2002 Jun;43(2):129-33. doi: 10.1016/s0732-8893(02)00387-5. Diagn Microbiol Infect Dis. 2002. PMID: 12088620

7

Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.

Pelak BA, Citron DM, Motyl M, Goldstein EJ, Woods GL, Teppler H. Pelak BA, et al. Among authors: woods gl. J Antimicrob Chemother. 2002 Nov;50(5):735-41. doi: 10.1093/jac/dkf203. J Antimicrob Chemother. 2002. PMID: 12407133

8

Ertapenem therapy for community-acquired pneumonia in the elderly.

Woods GL, Isaacs RD, McCarroll KA, Friedland IR. Woods GL, et al. J Am Geriatr Soc. 2003 Nov;51(11):1526-32. doi: 10.1046/j.1532-5415.2003.51507.x. J Am Geriatr Soc. 2003. PMID: 14687380 Clinical Trial.

9

Safety and tolerability of ertapenem.

Teppler H, Gesser RM, Friedland IR, Woods GL, Meibohm A, Herman G, Mistry G, Isaacs R. Teppler H, et al. Among authors: woods gl. J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii75-81. doi: 10.1093/jac/dkh209. J Antimicrob Chemother. 2004. PMID: 15150186 Review.

10

Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia.

Friedland IR, McCarroll KA, DiNubile MJ, Woods GL. Friedland IR, et al. Among authors: woods gl. Pulm Pharmacol Ther. 2004;17(4):199-203. doi: 10.1016/j.pupt.2004.03.002. Pulm Pharmacol Ther. 2004. PMID: 15219264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters